Publications by authors named "Hewei Ge"

Claim this Profile
B
Biologically-informed integration of drug representations for breast cancer treatment using deep learning.
Hewei Ge, Hongnan Mo, Yuhan Wei, Jiani Wang, Yalong Qi

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-cohort validation of a lipid metabolism and ferroptosis-associated index for prognosis and immunotherapy response prediction in hormone receptor-positive breast cancer.
Cheng Zeng, Jiani Wang, Shen Zhao, Yuhan Wei, Yalong Qi, Hewei Ge

Int J Biol Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic immune characteristics predicting toxicity to immune checkpoint inhibitors in patients with advanced breast cancer.
Yalong Qi, Hewei Ge, Xiaoying Sun, Yuhan Wei, Jingtong Zhai

J Autoimmun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive circulating biomarkers of the response to anti-PD-1 immunotherapy in advanced HER2 negative breast cancer.
Yuhan Wei, Hewei Ge, Yalong Qi, Cheng Zeng, Xiaoying Sun

Clin Transl Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy of anthracycline-free and anthracycline-containing neoadjuvant chemoimmunotherapy regimens for triple-negative breast cancer.
Yuhan Wei, Qiao Li, Hongnan Mo, Yalong Qi, Hewei Ge

Transl Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrotinib and trastuzumab combination treatment synergistically overcomes HER2 dependency in HER2-positive breast cancer: insights from the PHILA trial.
Shuning Liu, Bo Lan, Yuanyi Wang, Tao Yang, Lixi Li, Hewei Ge

EBioMedicine· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial.
Hongnan Mo, Yongpei Yu, Xiaoying Sun, Hewei Ge, Lanlan Yu

Nat Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic factors in the pathogenesis of cardio-oncology.
Yalong Qi, Yuhan Wei, Lixi Li, Hewei Ge, Yuanyi Wang

J Transl Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applications of digital Medicine in oncology: Prospects and challenges.
Hewei Ge, Lixi Li, Di Zhang, Fei Ma

Cancer Innov· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis